345 related articles for article (PubMed ID: 24439979)
1. Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (The Heart and Soul Study).
Schopfer DW; Ku IA; Regan M; Whooley MA
Am Heart J; 2014 Feb; 167(2):186-192.e1. PubMed ID: 24439979
[TBL] [Abstract][Full Text] [Related]
2. Relation of obesity to heart failure hospitalization and cardiovascular events in persons with stable coronary heart disease (from the Heart and Soul Study).
Spies C; Farzaneh-Far R; Na B; Kanaya A; Schiller NB; Whooley MA
Am J Cardiol; 2009 Oct; 104(7):883-9. PubMed ID: 19766751
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction.
Izumiya Y; Hanatani S; Kimura Y; Takashio S; Yamamoto E; Kusaka H; Tokitsu T; Rokutanda T; Araki S; Tsujita K; Tanaka T; Yamamuro M; Kojima S; Tayama S; Kaikita K; Hokimoto S; Ogawa H
Can J Cardiol; 2014 Mar; 30(3):338-44. PubMed ID: 24484911
[TBL] [Abstract][Full Text] [Related]
5. NSAID use and association with cardiovascular outcomes in outpatients with stable atherothrombotic disease.
Kohli P; Steg PG; Cannon CP; Smith SC; Eagle KA; Ohman EM; Alberts MJ; Hoffman E; Guo J; Simon T; Sorbets E; Goto S; Bhatt DL;
Am J Med; 2014 Jan; 127(1):53-60.e1. PubMed ID: 24280110
[TBL] [Abstract][Full Text] [Related]
6. Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.
Anand IS; Kempf T; Rector TS; Tapken H; Allhoff T; Jantzen F; Kuskowski M; Cohn JN; Drexler H; Wollert KC
Circulation; 2010 Oct; 122(14):1387-95. PubMed ID: 20855664
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of heart rate at rest as a predictor of mortality, hospitalization for heart failure, myocardial infarction, and stroke in patients with stable coronary heart disease (Data from the Treating to New Targets [TNT] trial).
Ho JE; Bittner V; Demicco DA; Breazna A; Deedwania PC; Waters DD
Am J Cardiol; 2010 Apr; 105(7):905-11. PubMed ID: 20346304
[TBL] [Abstract][Full Text] [Related]
8. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Wallentin L; Hijazi Z; Andersson U; Alexander JH; De Caterina R; Hanna M; Horowitz JD; Hylek EM; Lopes RD; Asberg S; Granger CB; Siegbahn A;
Circulation; 2014 Nov; 130(21):1847-58. PubMed ID: 25294786
[TBL] [Abstract][Full Text] [Related]
9. Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure.
Kempf T; von Haehling S; Peter T; Allhoff T; Cicoira M; Doehner W; Ponikowski P; Filippatos GS; Rozentryt P; Drexler H; Anker SD; Wollert KC
J Am Coll Cardiol; 2007 Sep; 50(11):1054-60. PubMed ID: 17825714
[TBL] [Abstract][Full Text] [Related]
10. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy.
Damman P; Kempf T; Windhausen F; van Straalen JP; Guba-Quint A; Fischer J; Tijssen JG; Wollert KC; de Winter RJ; Hirsch A;
Int J Cardiol; 2014 Mar; 172(2):356-63. PubMed ID: 24502880
[TBL] [Abstract][Full Text] [Related]
11. Relation between preoperative renal dysfunction and cardiovascular events (stroke, myocardial infarction, or heart failure or death) within three months of isolated coronary artery bypass grafting.
Holzmann MJ; Sartipy U
Am J Cardiol; 2013 Nov; 112(9):1342-6. PubMed ID: 23870631
[TBL] [Abstract][Full Text] [Related]
12. Positive affect and survival in patients with stable coronary heart disease: findings from the Heart and Soul Study.
Hoen PW; Denollet J; de Jonge P; Whooley MA
J Clin Psychiatry; 2013 Jul; 74(7):716-22. PubMed ID: 23945449
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Yang J
Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
[TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment and risk of cardiovascular events and mortality.
O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
[TBL] [Abstract][Full Text] [Related]
15. Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.
Rutledge T; Reis SE; Olson MB; Owens J; Kelsey SF; Pepine CJ; Mankad S; Rogers WJ; Merz CN; Sopko G; Cornell CE; Sharaf B; Matthews KA; Vaccarino V
Arch Gen Psychiatry; 2006 Aug; 63(8):874-80. PubMed ID: 16894063
[TBL] [Abstract][Full Text] [Related]
16. Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
Hagström E; Held C; Stewart RA; Aylward PE; Budaj A; Cannon CP; Koenig W; Krug-Gourley S; Mohler ER; Steg PG; Tarka E; Östlund O; White HD; Siegbahn A; Wallentin L;
Clin Chem; 2017 Jan; 63(1):325-333. PubMed ID: 27811204
[TBL] [Abstract][Full Text] [Related]
17. Growth-differentiation factor-15 and major cardiac events.
Lin JF; Wu S; Hsu SY; Yeh KH; Chou HH; Cheng ST; Wu TY; Hsu WT; Yang CC; Ko YL
Am J Med Sci; 2014 Apr; 347(4):305-11. PubMed ID: 24521768
[TBL] [Abstract][Full Text] [Related]
18. Association of Fibroblast Growth Factor 23 With Recurrent Cardiovascular Events in Patients After an Acute Coronary Syndrome: A Secondary Analysis of a Randomized Clinical Trial.
Bergmark BA; Udell JA; Morrow DA; Cannon CP; Steen DL; Jarolim P; Budaj A; Hamm C; Guo J; Im K; Kuder JF; Braunwald E; Sabatine MS; O'Donoghue ML
JAMA Cardiol; 2018 Jun; 3(6):473-480. PubMed ID: 29710336
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
Tuñón J; Blanco-Colio L; Cristóbal C; Tarín N; Higueras J; Huelmos A; Alonso J; Egido J; Asensio D; Lorenzo Ó; Mahíllo-Fernández I; Rodríguez-Artalejo F; Farré J; Martín-Ventura JL; López-Bescós L
Am J Cardiol; 2014 Feb; 113(3):434-40. PubMed ID: 24295549
[TBL] [Abstract][Full Text] [Related]
20. Association of growth differentiation factor 11/8, putative anti-ageing factor, with cardiovascular outcomes and overall mortality in humans: analysis of the Heart and Soul and HUNT3 cohorts.
Olson KA; Beatty AL; Heidecker B; Regan MC; Brody EN; Foreman T; Kato S; Mehler RE; Singer BS; Hveem K; Dalen H; Sterling DG; Lawn RM; Schiller NB; Williams SA; Whooley MA; Ganz P
Eur Heart J; 2015 Dec; 36(48):3426-34. PubMed ID: 26294790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
